Mar 03, 2017
1:14
For every 14 shares held, investors received 1.
The split itself did not change the total investment value.
Medicenna Therapeutics Corp. (NEO:MDNA) operates in the Biotechnology industry.
Medicenna Therapeutics Corp. company overviewMedicenna Therapeutics Corp.'s most recent stock split was on March 3, 2017. It was a 1-for-14 reverse split, so shareholders received 1 share for every 14 they held.
Medicenna Therapeutics Corp. has split its stock once. This history records one reverse split, on March 3, 2017.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Medicenna Therapeutics Corp.'s 1-for-14 reverse split on March 3, 2017, every 14 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Medicenna Therapeutics Corp. has not announced a new split in our records. Its most recent split was on March 3, 2017, 9 years ago. Companies announce splits in advance, and any new NEO:MDNA split will appear on this page.
Already premium?